Sporadic Creutzfeldt–Jakob Disease: MRI Diagnosis, Cortical Ribboning, Pulvinar Sign, DWI, RT-QuIC, and AI
When Rapidly Progressive Dementia Is Not Alzheimer’s Disease
A patient in her early sixties develops progressive memory impairment. At first, the symptoms seem compatible with a common neurodegenerative dementia. Several months later, however, the clinical picture becomes increasingly unusual: gait instability, dysphagia, behavioral changes, reduced speech, abnormal eye movements, and rapidly worsening cognitive function.
The brain CT may appear almost normal.
This is the moment when the diagnostic strategy must change.
In a patient with rapidly progressive dementia, the combination of cognitive decline and rapidly accumulating neurological deficits should immediately broaden the differential diagnosis beyond Alzheimer’s disease and vascular dementia. One of the most important diagnoses to consider is sporadic Creutzfeldt–Jakob disease (sCJD), a rapidly progressive and fatal prion disease.
The case presented in the accompanying material illustrates this diagnostic challenge particularly well. A 61-year-old woman experienced approximately 15 months of progressive cognitive deterioration, initially accompanied by balance disturbance and dysphagia, followed by emotional and behavioral changes, writing difficulty, memory impairment, urinary incontinence, reduced speech, and progressive gait and swallowing impairment.
The central lesson is simple:
A nearly normal CT does not exclude Creutzfeldt–Jakob disease. In rapidly progressive dementia, diffusion-weighted MRI can completely redirect the diagnostic pathway.
1. What Is Sporadic Creutzfeldt–Jakob Disease?
Creutzfeldt–Jakob disease belongs to the group of human prion diseases, also known as transmissible spongiform encephalopathies.
The disease is characterized by the accumulation of abnormally folded prion protein within the central nervous system. This abnormal protein promotes conformational conversion of normally folded cellular prion protein into pathogenic forms. Progressive protein misfolding is associated with neuronal dysfunction, neuronal loss, gliosis, and the characteristic spongiform changes of prion disease.
CJD has several major forms:
Sporadic CJD (sCJD)
Genetic or familial CJD
Iatrogenic CJD
Variant CJD (vCJD)
Sporadic CJD is the most common form.
Modern understanding of sCJD has also moved beyond the concept of a single uniform disease. Molecular subtypes associated with the PRNP codon 129 polymorphism and prion protein characteristics can produce distinct clinical phenotypes and MRI involvement patterns.
This heterogeneity is one reason why MRI findings should be interpreted as a pattern rather than as a single diagnostic sign.
2. Pathophysiology: Why Does CJD Progress So Rapidly?
The fundamental biological event is an abnormal change in protein conformation.
Normal cellular prion protein, commonly referred to as PrPC, can undergo structural conversion into an abnormal conformer associated with prion disease. The abnormal protein can then promote further misfolding, creating a self-propagating process.
The resulting pathological cascade includes:
Abnormal prion protein accumulation
Synaptic and neuronal dysfunction
Neuronal loss
Reactive gliosis
Spongiform degeneration
Progressive loss of neurological function
The clinical consequence is dramatically different from the typical time course of Alzheimer’s disease.
A patient with Alzheimer’s disease usually develops cognitive impairment over years. A patient with sCJD may deteriorate over months, with multiple neurological systems becoming involved in rapid succession.
This distinction is clinically crucial.
The accompanying case demonstrates this multidomain progression: cognitive impairment was followed by gait dysfunction, dysphagia, behavioral changes, language reduction, urinary dysfunction, and abnormal eye movements.
3. Epidemiology: A Rare Disease That Should Not Be Missed
Sporadic CJD is rare, but its importance in neurological practice is disproportionate to its incidence because it is rapidly progressive and fatal.
Contemporary surveillance and review literature generally places the incidence of CJD at approximately 1–2 cases per million people per year, with the sporadic form accounting for the large majority of cases.
The typical age of onset is in later adulthood. A 2024 UK surveillance analysis reported a mean age of onset of approximately 68 years.
The disease occurs worldwide.
For the radiologist, however, epidemiology should never become a reason to overlook the diagnosis.
The correct question is not:
“How rare is CJD?”
The correct question is:
“Does this patient have the clinical and MRI pattern of a rapidly progressive prion disease?”
That change in perspective is particularly important when evaluating rapidly progressive dementia.
4. Clinical Presentation: Recognizing the Rapidly Progressive Dementia Syndrome
The clinical spectrum of sCJD is broad.
Common manifestations include:
Rapidly progressive cognitive decline
Memory impairment
Behavioral or psychiatric changes
Ataxia
Gait disturbance
Myoclonus
Dysarthria
Dysphagia
Visual symptoms
Extrapyramidal or pyramidal signs
Abnormal eye movements
Reduced speech
Progressive functional dependence
The case in this article is particularly instructive because the symptoms did not remain confined to cognition.
The patient developed progressive gait impairment, dysphagia, behavioral changes, writing abnormalities, memory impairment, urinary incontinence, reduced language output, and abnormal ocular movements.
This is a rapidly progressive neurological syndrome, not simply “dementia.”
That distinction should influence the MRI protocol and the radiologist’s search pattern.
5. Figure 1 — CT: Why a Nearly Normal CT Does Not Exclude CJD
Figure 1. Axial non-contrast brain CT.
Radiologic interpretation:
The axial brain CT demonstrates no convincing acute structural lesion explaining the patient's rapidly progressive neurological deterioration. There is no large intracranial hemorrhage, mass lesion, hydrocephalus, or large territorial infarction. A mild anterior septal deviation is present but is not clinically explanatory.
The CT finding is important precisely because it is relatively unrevealing.
A normal or near-normal CT should not terminate the investigation in a patient with rapidly progressive dementia.
CT is excellent for excluding major structural causes such as:
Hemorrhage
Large infarction
Mass effect
Hydrocephalus
Major traumatic injury
But CJD is primarily a microscopic and functional neurodegenerative process. Conventional CT may therefore provide little diagnostic information.
Clinical pearl:
When CT does not explain rapidly progressive cognitive and neurological decline, MRI—particularly DWI and ADC—should be considered early.
6. Figure 2 and Figure 3 — DAT SPECT: When Parkinsonism Is a False Lead
The patient had an unstable, narrow-based gait and abnormal eye movements, raising consideration of an atypical parkinsonian syndrome.
A 123I-ioflupane dopamine transporter SPECT (DAT SPECT) study was therefore performed.
Figure 2. Axial 123I-ioflupane SPECT
Radiologic interpretation:
Symmetric tracer uptake is demonstrated in the bilateral striata, without convincing asymmetric reduction.
Figure 3. Coronal 123I-ioflupane SPECT
Radiologic interpretation:
The bilateral striatal uptake demonstrates a preserved, symmetric crescent-shaped distribution.
The case material interprets these findings as not supporting a typical degenerative dopaminergic parkinsonian syndrome.
This is an important diagnostic lesson.
A patient may look parkinsonian without actually having Parkinson’s disease.
When gait impairment occurs together with rapidly progressive dementia, dysphagia, abnormal eye movements, and cortical or basal ganglia MRI abnormalities, the diagnostic frame must expand.
7. MRI: The Examination That Changes the Diagnosis
MRI is the most important imaging examination in suspected sCJD.
The essential sequences are:
T1-weighted imaging
T2-weighted imaging
FLAIR
DWI
ADC
GRE or susceptibility-sensitive imaging
Among these, DWI is particularly important.
The characteristic MRI abnormalities described in the present case include:
Bilateral caudate hyperintensity
Putaminal/striatal involvement
Extensive cortical abnormalities
Restricted diffusion
Bilateral pulvinar involvement
Dorsomedial thalamic involvement
Prominent cingulate cortical signal abnormality
A large meta-analysis of DWI in sCJD reported a pooled diagnostic yield of approximately 91%, with pooled sensitivity of 91% and specificity of 97% in patients with rapidly progressive dementia.
This makes DWI one of the most powerful imaging tools in the evaluation of suspected sCJD.
8. Figure 4 — T1-Weighted MRI
Figure 4. Axial T1-weighted brain MRI.
Radiologic interpretation:
The T1-weighted images do not demonstrate a dominant mass lesion or another major structural abnormality capable of explaining the rapidly progressive neurological syndrome.
T1-weighted MRI remains valuable because it establishes structural anatomy, assesses global cerebral volume loss, and helps exclude alternative diagnoses.
However, T1-weighted imaging is not the sequence on which the diagnosis of sCJD should primarily depend.
The critical abnormality may be much more conspicuous on DWI than on conventional T1-weighted imaging.
9. Figure 5 — T2-Weighted MRI
Figure 5. Axial T2-weighted brain MRI.
Radiologic interpretation:
Abnormal signal is present within deep gray matter and cortical structures, although the conspicuity of the abnormality is less striking than on diffusion-weighted imaging.
This illustrates an important practical principle:
In suspected CJD, do not stop after reviewing T1 and T2 images.
The DWI and ADC maps may contain the decisive information.
10. Figure 6 — FLAIR and the Cortical Ribboning Pattern
Figure 6. Axial FLAIR MRI.
Radiologic interpretation:
Multifocal cortical and basal ganglia hyperintensity is present, with particularly conspicuous cortical signal abnormality involving the cingulate region. The gyriform cortical signal pattern corresponds to the classic imaging concept of cortical ribboning.
Cortical ribboning describes abnormal signal following the cerebral cortical ribbon.
It is one of the most recognizable imaging patterns associated with sCJD.
But there is a critical caveat:
Cortical ribboning is not synonymous with CJD.
Similar cortical diffusion abnormalities can occur with:
Hypoglycemic encephalopathy
Hypoxic-ischemic injury
Status epilepticus
Encephalitis
Other toxic-metabolic disorders
Therefore, the radiologist should not diagnose CJD from cortical ribboning alone.
The correct interpretation is:
Clinical phenotype + distribution + DWI/ADC behavior + basal ganglia involvement + laboratory biomarkers.
11. Figure 7 — DWI: The Most Important Image in the Case
Figure 7. Axial diffusion-weighted MRI.
Radiologic interpretation:
Marked diffusion restriction is demonstrated involving the cerebral cortex and deep gray nuclei, particularly the bilateral caudate/putaminal regions. The distribution is not confined to a single vascular territory and is highly suggestive of a prion-related rapidly progressive encephalopathy in the appropriate clinical context.
This is the key imaging finding in the case.
The classic sCJD pattern includes restricted diffusion involving:
Cerebral cortex
Caudate nucleus
Putamen
Sometimes thalamus
Less commonly cerebellum
The original MRI-CJD Consortium study found that MRI was positive in approximately 83% of sCJD cases and identified cortical and caudate/putaminal signal abnormalities as highly useful diagnostic patterns.
More recent evidence continues to support the high diagnostic value of DWI.
12. Why DWI Works So Well in CJD
The exact biological mechanism underlying DWI abnormalities in CJD is complex, but restricted diffusion is thought to reflect pathological changes associated with neuronal injury, spongiform degeneration, and altered water mobility.
The important radiological observation is not simply that the cortex is bright on DWI.
The radiologist should ask:
Is the corresponding ADC reduced?
True diffusion restriction is much more meaningful when DWI hyperintensity corresponds to low ADC.
This is particularly important because T2 shine-through can mimic diffusion restriction.
A modern CJD MRI interpretation should therefore evaluate DWI together with ADC, rather than interpreting DWI in isolation.
13. The Five-Step MRI Rule for Suspected sCJD
For a patient with rapidly progressive dementia, a practical approach is:
14. Figure 8 — GRE and the Role of Susceptibility Imaging
Figure 8. Axial GRE MRI.
Radiologic interpretation:
The susceptibility-sensitive sequence does not provide the primary diagnostic signature of sCJD. Its major value is in assessing hemorrhage and other susceptibility-related abnormalities and in excluding alternative structural causes as part of a comprehensive MRI protocol.
GRE is therefore complementary rather than diagnostic.
In modern brain MRI, the sequence should be interpreted in the context of the entire examination.
15. Pulvinar Sign: Famous, Useful, and Easy to Misinterpret
One of the most famous signs associated with prion disease is the pulvinar sign.
It refers to bilateral increased signal in the pulvinar nuclei of the thalamus.
Historically, this sign became strongly associated with variant CJD.
But the current case provides an important warning.
The patient had bilateral pulvinar and dorsomedial thalamic abnormalities, yet the final diagnosis was sporadic CJD.
Therefore:
Pulvinar sign does not automatically mean variant CJD.
It can occur in sCJD and in other neurological conditions.
The radiologist should never report:
“Pulvinar sign = variant CJD.”
Instead, the imaging pattern should be integrated with:
Patient age
Clinical phenotype
Disease progression
Cortical involvement
Striatal involvement
DWI pattern
Epidemiological history
CSF biomarkers
PRNP/genetic information when appropriate
16. Hockey Stick Sign
When the dorsomedial thalamus is involved together with the pulvinar, the resulting configuration has been described as the hockey stick sign.
It is particularly recognized in variant CJD, but it is not absolutely specific.
The safest interpretation is therefore:
Pulvinar + dorsomedial thalamus + cortical ribboning + basal ganglia involvement + clinical phenotype
rather than relying on one named sign.
The case material explicitly emphasizes that both pulvinar and hockey-stick signs may occur outside vCJD.
17. Sporadic CJD Versus Variant CJD
| Feature | Sporadic CJD | Variant CJD |
|---|---|---|
| Frequency | Commonest CJD form | Very rare |
| Typical age | Older adults | Often younger |
| Rapid dementia | Common | May occur |
| Cortical involvement | Common | Less characteristic |
| Caudate/putamen involvement | Common | Possible |
| Pulvinar sign | Can occur | Characteristic |
| Hockey-stick sign | Can occur | Characteristic |
| DWI cortical ribboning | Important | Possible |
| Final subtype confirmation | Requires integrated clinical/pathological/genetic assessment | Requires integrated clinical/pathological assessment |
MRI can strongly suggest a prion disease phenotype, but it should not be used in isolation to assign a definitive CJD subtype.
18. Differential Diagnosis: The MRI Mimics That Matter
A high-quality CJD diagnosis requires an equally high-quality differential diagnosis.
Hypoglycemic Encephalopathy
Severe hypoglycemia can produce cortical and basal ganglia diffusion restriction.
Therefore:
Check the glucose history.
Hypoxic-Ischemic Brain Injury
After cardiac arrest or severe hypoxemia, widespread cortical and deep gray matter diffusion restriction can mimic CJD.
The clinical history is decisive.
Status Epilepticus
Seizure activity can cause cortical DWI restriction.
EEG is particularly important when the clinical picture is compatible with ongoing or recent seizure activity.
Autoimmune Encephalitis
This is among the most important differential diagnoses because it may be treatable.
A patient should not be labeled as having CJD before reasonable evaluation for potentially reversible autoimmune encephalopathy.
Viral Encephalitis
Temporal lobe-predominant abnormalities, particularly with inflammatory clinical features, should raise concern for infectious encephalitis such as HSV.
Wernicke Encephalopathy
Thalamic and periaqueductal abnormalities may create diagnostic overlap.
Carbon Monoxide Toxicity
Globus pallidus involvement can be an important clue.
Acute Ischemic Stroke
A vascular-territory distribution should favor infarction rather than CJD.
This is especially important when DWI abnormalities are extensive.
The supplied case material specifically emphasizes hypoglycemia, carbon monoxide toxicity, hypoxic injury, status epilepticus, autoimmune encephalitis, viral encephalitis, Wernicke encephalopathy, and acute infarction as important alternatives.
19. Diagnosis: MRI Is Powerful, but It Is Not the Entire Diagnosis
The modern diagnosis of sCJD is multimodal.
The diagnostic pathway can be conceptualized as:
The supplied case followed this general logic, with CSF 14-3-3 and total tau abnormalities supporting the diagnosis and RT-QuIC representing a particularly important modern biomarker.
20. Why RT-QuIC Has Changed CJD Diagnosis
The development of real-time quaking-induced conversion (RT-QuIC) represents one of the most important advances in prion disease diagnosis.
Unlike 14-3-3, which reflects rapid neuronal injury but is not specific to prion disease, RT-QuIC detects prion-associated seeding activity.
This difference is clinically important.
A patient with:
Rapidly progressive dementia
Characteristic DWI abnormalities
Positive RT-QuIC
has a substantially stronger diagnostic case than a patient with elevated 14-3-3 alone.
The supplied case cites international evidence supporting high RT-QuIC performance and notes a validation study reporting sensitivity of approximately 91.6% and specificity of 100%.
Modern diagnostic reviews emphasize that RT-QuIC has substantially strengthened confident ante-mortem diagnosis of sCJD.
21. Treatment: The Most Important Treatment May Be Treating the Correct Diagnosis
There is currently no established disease-modifying cure for sporadic CJD.
Management is therefore largely supportive.
Important components include:
Dysphagia management
Nutritional support
Fall prevention
Infection prevention and treatment
Symptom control
Management of myoclonus or other distressing symptoms
Caregiver education
Palliative care
Avoidance of unnecessary invasive procedures
The case material emphasizes the importance of supportive care and appropriate exclusion of treatable rapidly progressive encephalopathies before concluding that a patient has CJD.
This is one of the most important clinical lessons.
The diagnosis of CJD should not become an excuse to stop searching for treatable mimics.
Autoimmune encephalitis, infectious encephalitis, metabolic encephalopathy, endocrine disorders, toxic conditions, and medication-related disorders can sometimes be treated.
22. Prognosis
Sporadic CJD is relentlessly progressive and ultimately fatal.
Survival is generally short, although considerable variation exists between molecular subtypes and individual patients.
The importance of early diagnosis therefore extends beyond extending survival.
Accurate diagnosis can:
Reduce unnecessary investigations
Prevent inappropriate treatments
Improve communication with families
Support advance-care planning
Facilitate palliative care
Improve infection-control planning
Reduce unnecessary medical interventions
The case material appropriately emphasizes that the value of MRI extends beyond image interpretation into patient-centered decision-making.
23. The New Role of Artificial Intelligence in CJD
Artificial intelligence is beginning to change the way rare neurological diseases are analyzed.
However, there is an important distinction between:
AI research capability
and
clinically validated AI deployment.
CJD is rare, heterogeneous, and difficult to collect at the scale required for conventional deep-learning development.
Nevertheless, several important research directions have emerged.
AI Application 1 — MRI Pattern Recognition
Machine-learning approaches can analyze spatial distributions of DWI abnormalities that may be difficult to quantify manually.
One particularly interesting approach used a discriminative event-based model to reconstruct disease-specific sequences of MRI abnormalities.
In a study of 488 autopsy-confirmed sCJD cases and controls, the model identified subtype-specific spatial cascades and achieved approximately 76.5% balanced accuracy for sCJD subtype classification.
This is important because different sCJD molecular subtypes may produce different patterns of cortical, striatal, thalamic, and cerebellar involvement.
AI may therefore eventually help answer a question that conventional MRI reporting cannot answer reliably:
“Which molecular phenotype is this imaging pattern most compatible with?”
24. AI Application 2 — Deep Learning of CSF Biomarkers
AI has also been applied to CSF biomarkers.
A Korean study developed a deep-learning model using multiple CSF proteins, including:
14-3-3
Total tau
Phosphorylated tau
α-synuclein
Aβ42
The objective was to improve discrimination between sCJD and non-CJD neurological disorders.
This illustrates an important future direction:
AI should not analyze MRI in isolation.
The strongest CJD decision-support system may ultimately integrate:
MRI + ADC + CSF RT-QuIC + 14-3-3 + tau + EEG + clinical phenotype + genetics
into one multimodal model.
25. AI Application 3 — Prognosis Prediction
Perhaps even more clinically meaningful than diagnosis is prognosis.
A 2024 study developed an interpretable deep-learning survival model using data from 655 UK sCJD cases, incorporating clinical findings, MRI, EEG, CSF RT-QuIC, 14-3-3, age, sex, PRNP codon 129 polymorphism, and other variables.
The model achieved a concordance index of 0.732, with AUC values of 0.866 at five months and 0.872 at ten months.
This represents a potentially important shift:
AI may ultimately help clinicians estimate not only:
“Does this patient have CJD?”
but also:
“What is the likely disease trajectory?”
Such information could support individualized care planning and communication with families.
26. AI Application 4 — EEG-Based CJD Detection
More recent research has explored AI analysis of EEG.
A 2026 study described a lightweight hybrid model combining convolutional neural networks and Transformer architecture to distinguish Alzheimer’s disease, CJD, and healthy controls. The reported average classification accuracy was approximately 97% in a small local cohort.
These findings are scientifically interesting, but they should not be interpreted as evidence that an AI EEG classifier is ready to replace neurological diagnosis.
The cohort was small, and generalizability remains a major issue.
This is a recurring problem in rare-disease AI:
High accuracy in a small dataset does not automatically equal clinical utility.
27. What the Future CJD AI Platform Could Look Like
A future CJD decision-support system could potentially operate as follows:
This would represent a transition from simple image detection to multimodal neurological intelligence.
28. But AI Must Not Replace the Neuroradiologist
AI has an important limitation.
CJD is a rare disease with multiple mimics and substantial clinical heterogeneity.
An algorithm can identify a pattern.
It cannot independently determine whether the patient has:
autoimmune encephalitis,
metabolic encephalopathy,
status epilepticus,
hypoxic injury,
toxic encephalopathy,
infection,
or a prion disease.
The future is therefore not:
AI versus radiologist.
It is:
AI + neuroradiologist + neurologist + laboratory biomarkers.
This is especially important because recent work evaluating updated MRI criteria has demonstrated that even experienced human readers can have only moderate inter-rater reliability.
AI may improve consistency, but it must be externally validated across institutions, scanners, acquisition protocols, ethnic populations, and disease subtypes before routine clinical adoption.
29. A Practical CJD MRI Reporting Template
A useful radiology report might state:
Findings
“Restricted diffusion is demonstrated involving the bilateral cerebral cortex and striatum, including the caudate nuclei and putamina, with corresponding ADC reduction. Associated cortical FLAIR hyperintensity produces a cortical ribboning pattern. Bilateral thalamic involvement, including the pulvinar and dorsomedial thalamic regions, is also present.”
Impression
“Multifocal cortical and striatal diffusion restriction, including bilateral caudate/putaminal involvement, in the setting of rapidly progressive cognitive decline. The pattern is highly suggestive of sporadic Creutzfeldt–Jakob disease. Clinical correlation and exclusion of treatable rapidly progressive encephalopathies are recommended. CSF RT-QuIC may provide important additional diagnostic confirmation.”
This type of report is more clinically useful than simply stating:
“Cortical ribboning.”
Quiz
Question 1
A 61-year-old woman develops rapidly progressive cognitive decline, gait impairment, and dysphagia. CT shows no explanatory structural lesion. MRI demonstrates bilateral caudate and putaminal diffusion restriction with cortical ribboning.
What is the most likely diagnosis?
A. Hypoxic-ischemic brain injury
B. Viral encephalitis
C. Sporadic Creutzfeldt–Jakob disease
D. Acute territorial infarction
E. Glioblastoma
Correct answer: C. Sporadic Creutzfeldt–Jakob disease
Explanation:
Rapidly progressive dementia combined with bilateral caudate/putaminal and cortical diffusion restriction is a classic imaging-clinical combination for sCJD. The MRI-CJD Consortium criteria established cortical and caudate/putaminal abnormalities as important diagnostic patterns.
Question 2
A patient suspected of having a degenerative parkinsonian syndrome undergoes 123I-ioflupane SPECT. Bilateral striatal tracer distribution is symmetric and preserved.
What is the most appropriate interpretation?
A. Strong evidence of Parkinson’s disease
B. Evidence of severe dopaminergic terminal loss
C. Reduced likelihood of a typical degenerative parkinsonian syndrome
D. Definitive confirmation of CJD
E. Definitive confirmation of Alzheimer’s disease
Correct answer: C. Reduced likelihood of a typical degenerative parkinsonian syndrome
Explanation:
The case demonstrates preserved symmetric DAT distribution. This finding does not establish CJD, but it makes a typical dopaminergic degenerative parkinsonian disorder less likely and encourages evaluation of alternative causes.
Question 3
MRI demonstrates bilateral pulvinar hyperintensity in a patient with rapidly progressive dementia.
Which statement is most accurate?
A. Pulvinar sign occurs exclusively in variant CJD
B. Pulvinar sign alone establishes the diagnosis of CJD
C. Pulvinar involvement can occur in sporadic CJD
D. Pulvinar sign is pathognomonic for Wernicke encephalopathy
E. No further differential diagnosis is necessary
Correct answer: C. Pulvinar involvement can occur in sporadic CJD
Explanation:
Although the pulvinar sign is classically associated with variant CJD, it can also occur in sporadic CJD and other neurological disorders. The present case itself demonstrates pulvinar and dorsomedial thalamic abnormalities despite the final diagnosis of sporadic CJD.
The CJD MRI Checklist
When evaluating rapidly progressive dementia, ask five questions:
1. Is there cortical ribboning?
2. Are the caudate nuclei involved?
3. Are the putamina involved?
4. Is there pulvinar or dorsomedial thalamic involvement?
5. Is the abnormality truly diffusion-restricting on ADC?
If these findings occur together with a rapidly progressive neurological syndrome, the probability of sCJD rises substantially.
The original case material summarizes essentially the same five-step approach.
Final Clinical Perspective
The most important lesson from this case is not the pulvinar sign.
It is not even cortical ribboning.
The most important lesson is pattern recognition in the correct clinical context.
A patient with slowly progressive memory loss may reasonably enter a conventional dementia pathway.
A patient with rapidly progressive cognitive decline, gait disturbance, dysphagia, behavioral changes, abnormal eye movements, and progressive neurological dysfunction requires a different diagnostic framework.
In that setting, MRI—particularly DWI and ADC—can become the decisive examination.
The most informative imaging combination is:
DWI restriction + cortical ribboning + caudate/putamen involvement
with possible:
pulvinar + dorsomedial thalamic involvement
The diagnosis should then be integrated with EEG and CSF biomarkers, especially RT-QuIC.
The major diagnostic danger is not simply missing CJD.
It is diagnosing CJD too early and thereby missing a treatable rapidly progressive encephalopathy.
Modern CJD diagnosis is therefore a multimodal process.
MRI identifies the pattern.
CSF biomarkers strengthen the diagnosis.
RT-QuIC provides disease-specific prion seeding evidence.
EEG contributes complementary physiological information.
AI may eventually integrate these signals and provide automated pattern recognition, subtype prediction, and prognostic estimates.
But the final clinical decision still belongs to the multidisciplinary team.
The radiologist's most valuable contribution may be a single sentence:
“Rapidly progressive dementia with cortical and striatal diffusion restriction should raise strong concern for sporadic Creutzfeldt–Jakob disease, while treatable rapidly progressive encephalopathies must be actively excluded.”
That sentence can change the entire diagnostic pathway.
Internal Link — MediAI
https://leesangbock.blogspot.com/2025/09/creutzfeldt-jakob-disease-cjd-causes.html
https://leesangbock.blogspot.com/2025/07/leptomeningeal-carcinomatosis-from.html
https://leesangbock.blogspot.com/2026/03/advanced-diagnostic-and-therapeutic.html
Recommended Reading
I. Zerr et al., “Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease,” Brain, vol. 132, no. 10, pp. 2659–2668, 2009.
DOI: 10.1093/brain/awp191D. C. Fragoso et al., “Imaging of Creutzfeldt-Jakob disease: Imaging patterns and their differential diagnosis,” RadioGraphics, vol. 37, no. 1, pp. 234–257, 2017.
DOI: 10.1148/rg.2017160075B. Meissner et al., “MRI lesion profiles in sporadic Creutzfeldt-Jakob disease,” Neurology, vol. 72, pp. 1994–2001, 2009.
DOI: 10.1212/WNL.0b013e3181a96e5dB. Meissner et al., “Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease,” AJNR, vol. 29, pp. 1519–1524, 2008.
DOI: 10.3174/ajnr.A1122L. I. Sanchez-Juan et al., “CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease,” Neurology, vol. 67, no. 4, pp. 637–643, 2006.
P. Park et al., “Real-Time Quaking-Induced Conversion Analysis for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease in Korea,” Journal of Clinical Neurology, vol. 12, no. 1, pp. 101–106, 2016.
DOI: 10.3988/jcn.2016.12.1.101L. I. McGuire et al., “Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic Creutzfeldt-Jakob disease: An international study,” Annals of Neurology, vol. 80, no. 1, pp. 160–165, 2016.
DOI: 10.1002/ana.24679B. R. Groveman et al., “Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis,” Annals of Clinical and Translational Neurology, vol. 4, no. 2, pp. 139–144, 2017.
DOI: 10.1002/acn3.378M. Cramm et al., “Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease,” Molecular Neurobiology, vol. 53, pp. 1896–1904, 2016.
DOI: 10.1007/s12035-015-9133-2D. Barber et al., “Assessing the newly proposed MRI criteria for diagnosing sporadic Creutzfeldt-Jakob disease,” Neuroradiology, vol. 66, no. 11, pp. 1907–1915, 2024.
DOI: 10.1007/s00234-024-03440-wJ. Tam et al., “Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease,” Journal of Neurology, vol. 272, article 62, 2025.
DOI: 10.1007/s00415-024-12815-1Y. Gao and P. Li, “Sporadic Creutzfeldt-Jakob disease: a multidimensional review from epidemiology to treatment and prognosis,” Journal of Neurology, vol. 273, no. 6, article 357, 2026.
DOI: 10.1007/s00415-026-13862-6
Comments
Post a Comment